LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring

From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics

(2021) Sebastian G. Wicha et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Analysis of the risk factors of linezolid‐related haematological toxicity in Chinese patients

(2021) Ying Dai et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: Availability, performance and barriers to implementation

(2021) Indy Sandaradura et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

(2020) A.-G. Märtson et al.   CLINICAL MICROBIOLOGY AND INFECTION

Impact of high plasma concentrations of linezolid in Taiwanese adult patients— therapeutic drug monitoring in improving adverse drug reactions

(2020) Chih-Ning Cheng et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study

(2019) Pier Giorgio Cojutti et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice

(2019) Gauri G Rao et al.   THERAPEUTIC DRUG MONITORING

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

(2017) Charles S Haworth et al.   THORAX

Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones

(2016) Dario Cattaneo et al.   Expert Opinion on Drug Metabolism & Toxicology

Therapeutic drug management of linezolid: a missed opportunity for clinicians?

(2016) Dario Cattaneo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis

(2015) T. Ichie et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

(2014) Lauren M. Boak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Linezolid Penetration Into Cerebrospinal Fluid and Brain Tissue

(2014) A. Tsona et al.   JOURNAL OF CHEMOTHERAPY

Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections

(2013) Dario Cattaneo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Influence of Linezolid Clearance on the Induction of Thrombocytopenia and Reduction of Hemoglobin

(2011) Yoichi Hiraki et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Pharmacological Issues of Linezolid

(2010) Antonello Di Paolo et al.   CLINICAL PHARMACOKINETICS

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction

(2010) Kazuaki Matsumoto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

(2010) Yoshiko Takahashi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly Patients

(2009) Sadahiro Abe et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections

(2008) J. Majcher-Peszynska et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY